Ungerer Garrett N, Pence Sierra T, Findlay Bridget L, Lee Yeonsoo S, Viers Boyd R, Anderson Katherine T, Warner Jonathan N
Department of Urology, Mayo Clinic, Rochester, MN, USA.
Department of Urology, Mayo Clinic, Jacksonville, FL, USA.
Transl Androl Urol. 2025 Aug 30;14(8):2383-2390. doi: 10.21037/tau-24-430. Epub 2025 Aug 4.
Membranous urethral strictures pose a challenging problem for reconstructive urologists given the difficult location and the impact on continence. Our study aims to expand on the surgical technique, outcomes, and complications of endoscopic buccal mucosal urethroplasty (EBMGU) in the treatment of membranous stricture disease. A single institution retrospective review of patients treated with EBMGU for management of membranous stricture disease between February 2022 and December 2024 was conducted. Patients with obliterative strictures and radiation were also included. Data collected included patient demographics, prior treatments, uroflow, post void residual volumes, stricture characteristics, intraoperative details, and complications. Patients with at least a 4-month follow-up cystoscopy were included. Surgical success was defined as the ability to pass a 17-Fr cystoscope into the bladder at the time of 4-month follow-up. Twenty-eight men are included in this study. Median age was 71 years (range, 46-85 years), and median follow-up was 8 months (range, 4-27 months). Twenty-four (85%) had prior radiation, and 4 had a history of pelvic fracture urethral injury (PFUI). Five (17%) patients had an obliterative stricture disease, 26 (93%) patients had at least one prior intervention, 23 (82%) were patent on 4-month cystoscopy, and these patients had a history of radiation. All patients with a history of PFUI were patent on a 4-month cystoscopy. Sixteen (57%) have gone on to receive an artificial urinary sphincter (AUS), 3 (10%) patients required cystectomy with urinary diversion. One for refractory hematuria due to radiation cystitis, one for refractory symptomatic bladder neck necrosis with sloughing, and one for delayed urosymphyseal fistula in the setting of extensive radionecrosis of the bladder neck. EBMGU is an effective option for management of membranous stricture disease in radiated patients in the short term. Four-month success rates were 82%. More than half of the patients went on to successful AUS placement.
由于膜性尿道狭窄位置特殊且会影响控尿功能,给重建泌尿外科医生带来了具有挑战性的难题。我们的研究旨在进一步探讨内镜下颊黏膜尿道成形术(EBMGU)治疗膜性狭窄疾病的手术技术、疗效及并发症。对2022年2月至2024年12月期间接受EBMGU治疗膜性狭窄疾病的患者进行了单机构回顾性研究。纳入了闭锁性狭窄和接受过放疗的患者。收集的数据包括患者人口统计学资料、既往治疗情况、尿流率、排尿后残余尿量、狭窄特征、术中细节及并发症。纳入至少有4个月随访膀胱镜检查结果的患者。手术成功定义为在4个月随访时能够将17F膀胱镜插入膀胱。本研究纳入了28名男性。中位年龄为71岁(范围46 - 85岁),中位随访时间为8个月(范围4 - 27个月)。24例(85%)有放疗史,4例有骨盆骨折尿道损伤(PFUI)病史。5例(17%)患者患有闭锁性狭窄疾病,26例(93%)患者至少接受过一次先前干预,23例(82%)在4个月膀胱镜检查时通畅,这些患者有放疗史。所有有PFUI病史的患者在4个月膀胱镜检查时均通畅。16例(57%)患者继而接受了人工尿道括约肌(AUS)植入,3例(10%)患者需要行膀胱切除术并尿流改道。1例因放射性膀胱炎导致难治性血尿,1例因难治性有症状膀胱颈坏死伴脱落,1例因膀胱颈广泛放射性坏死导致延迟性耻骨联合瘘。短期内,EBMGU是治疗放疗后患者膜性狭窄疾病的有效选择。4个月成功率为82%。超过一半的患者继而成功植入了AUS。